VDAC2 enables BAX to mediate apoptosis and limit tumor development

Area of Science:

• Cellular Biology
• Molecular Oncology
• Biochemistry

Background:

• Intrinsic apoptosis is crucial for tumor suppression and cancer therapy, mediated by BAX and BAK proteins.
• BAX and BAK are considered redundant effectors of apoptosis, regulated by similar mechanisms.
• The precise roles and regulation of BAX and BAK, particularly their interactions with mitochondrial proteins, require further elucidation.

Purpose of the Study:

• To identify novel regulators of apoptosis using a genome-wide CRISPR/Cas9 screen.
• To investigate the specific role of voltage-dependent anion channel 2 (VDAC2) in BAX and BAK function.
• To understand the differential regulation of BAX and BAK by VDAC2 in the context of cancer.

Main Methods:

• Genome-wide CRISPR/Cas9 screening to identify genes essential for apoptosis.
• Genetic deletion of VDAC2 in cellular models.
• Analysis of BAX and BAK association with mitochondrial complexes.
• Assessment of apoptotic function and tumor suppression capabilities.

Main Results:

• VDAC2 was identified as critical for BAX, but not BAK, apoptotic function.
• Genetic deletion of VDAC2 disrupted BAX/BAK association with mitochondrial VDAC complexes and impaired BAX-mediated apoptosis.
• Loss of VDAC2 phenocopied BAX loss, inhibiting anti-cancer agent efficacy and tumor suppression.

Conclusions:

• Efficient BAX-mediated apoptosis is dependent on VDAC2.
• VDAC2 plays a critical, non-redundant role in BAX function, distinct from its role in BAK.
• This study reveals a novel mechanism of BAX regulation by VDAC2, highlighting therapeutic potential in cancer treatment.